Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease1

Abstract

This preliminary encouraging result merits additional studies to optimize Enbrel as a potential complementary therapy for resolution of steroid-dependent cGVHD.